Target intelligence / Profile preview

Human skin microbiota

Molecular classification
Microbial community, Biological ecosystem, Other
01

Overview

The human skin microbiota is a complex and dynamic ecosystem comprising trillions of bacteria, fungi, viruses, and mites that inhabit various topographical niches of the human skin surface. It plays a fundamental role in host health by reinforcing the skin's physical and chemical barrier, producing antimicrobial peptides (AMPs), and modulating both innate and adaptive immune responses. This microbial community acts as a primary defense against environmental pathogens through competitive inhibition and the maintenance of an acidic skin pH environment. Disruptions to this delicate microbial balance, a state referred to as dysbiosis, are significantly associated with the pathogenesis of various dermatological disorders, including atopic dermatitis, acne vulgaris, and psoriasis. Therapeutic interventions aim to restore homeostasis through strategies such as the application of probiotics, prebiotics, and targeted antimicrobial agents like bacteriophages. Unlike traditional molecular targets, the microbiota represents a dynamic biological network that interactively influences host physiology and environmental response, making it a pivotal focus for modern dermatological research and therapeutic development.

Other names
Human skin microbiomeCutaneous microbiotaSkin microfloraCutaneous microbiome
02

Biological functions

Immune response modulationPhysical and chemical barrier protectionCompetitive inhibition of pathogensMetabolism of skin lipidsAntimicrobial peptide productionEducation of the immune system
03

Disease associations

Atopic dermatitisAcne vulgarisPsoriasisRosaceaSeborrheic dermatitisChronic wound infectionDandruff
04

Safety considerations

Risk of dysbiosis following broad-spectrum antimicrobial usePotential for systemic infection in immunocompromised hostsEmergence of antibiotic-resistant microbial strainsUnintended transfer of horizontal antibiotic resistance genesRegulatory and safety uncertainty regarding engineered live biotherapeutics
05

Interacting drugs

Erythromycin

7 more in the full profile.

06

Biomarkers

Shannon diversity indexMicrobial network connectivity biomarkersRelative abundance of Staphylococcus aureusStaphylococcus aureus to Staphylococcus epidermidis ratioCutibacterium acnes phylotype distribution

Beyond the preview

Go deeper on Human skin microbiota.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human skin microbiota.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call